Micosidine (Ointment) Instructions for Use

Marketing Authorization Holder

CHLS-VNIKhFI FSUE (Russia)

ATC Code

D01AE (Other antifungal drugs for topical use)

Dosage Form

Micosidine

Ointment for external use 3%: jars or tubes 30 g

Dosage Form, Packaging, and Composition

30 g – dark glass jars (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.

Clinical-Pharmacological Group

External antifungal drug

Pharmacotherapeutic Group

Antifungal agent

Pharmacological Action

Micosidine is an antifungal agent that exerts a fungicidal effect against dermatophytes (Microsporum canis, Trichophyton gyrseum, Trichophyton mentagrophytes, Trichophyton rubrum) and yeasts (Candida spp.).

The drug has an antibacterial effect against: Bacillus cereus, Fusobacterium nucleatum, Micrococcus spp., Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes.

Pharmacokinetics

After application, Micosidine is moderately absorbed into the systemic circulation, reaching C_max after 4 hours. It is excreted in urine and feces within the first 24 hours.

Indications

• Skin diseases caused by fungi sensitive to the drug: dermatophytes Microsporum canis, Trichophyton gyrseum, Trichophyton mentagrophytes, Trichophyton rubrum and yeasts of the genus Candida spp..

ICD codes

Dosage Regimen

Apply the ointment for external use only.

Before application, clean and dry the affected skin areas thoroughly.

Apply a thin layer of ointment to the affected areas and surrounding skin, gently rubbing it in.

Use the ointment once daily, preferably in the evening.

Do not cover the treated area with occlusive dressings unless specifically directed by a physician.

Wash hands thoroughly before and after each application to prevent spreading the infection.

The maximum daily dose must not exceed 5 grams of ointment.

The standard duration of treatment is from 2 to 8 weeks.

Continue treatment for at least 2 weeks after the complete resolution of clinical symptoms to prevent relapse.

If no clinical improvement is observed after 2 weeks of therapy, re-evaluate the diagnosis.

Do not use for longer than the prescribed period.

Adverse Reactions

Local reactions in the form of burning, itching, and redness of the skin are possible.

If side effects occur, treatment should be discontinued.

Contraindications

• Hypersensitivity to the components of the drug;
• Severe liver and kidney diseases;
• Children under 18 years of age;
• Pregnancy and lactation period.

Use in Pregnancy and Lactation

The use of this drug is contraindicated during pregnancy and lactation.

Use in Hepatic Impairment

Contraindicated in severe liver function diseases.

Use in Renal Impairment

Contraindicated in severe kidney function diseases.

Pediatric Use

Use in children and adolescents under 18 years of age is contraindicated.

Special Precautions

Contact of the drug with the eyes should be avoided.

Drug Interactions

Not described.

Storage Conditions

The drug should be stored in a dry place, protected from light, at a temperature not exceeding 15°C (59°F).

Keep out of reach of children.

Dispensing Status

The drug is dispensed by prescription.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.